MedPath
FDA Approval

Hydromorphone Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydromorphone(2 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

American Health Packaging

American Health Packaging

929561009

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydromorphone Hydrochloride

Product Details

NDC Product Code
60687-579
Application Number
ANDA076855
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 11, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: L960UP2KRWClass: ACTIBQuantity: 2 mg in 1 1

Hydromorphone Hydrochloride

Product Details

NDC Product Code
60687-590
Application Number
ANDA076855
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 11, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: L960UP2KRWClass: ACTIBQuantity: 4 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath
Hydromorphone Hydrochloride - FDA Approval | MedPath